The SPDR S&P Aerospace & Defense ETF (XAR) tracks the S&P Aerospace & Defense Select Industry Index, covering aircraft manufacturers, defense prime contractors, and a wide range of suppliers and service providers. Unlike many sector funds, XAR applies a modified equal-weighting methodology, so no single holding dominates the portfolio. This approach lowers concentration risk compared with market-cap-weighted alternatives and tilts exposure toward mid-cap and smaller-cap companies that may benefit more from new defense priorities. I also checked this using Tickeron’s AI Screener to see how the holdings compare to others in the industry.
The fund carries a 0.35% expense ratio and typically holds between roughly 40 and 50 names. Major exposures include RTX, GE Aerospace, Lockheed Martin, Northrop Grumman, Huntington Ingalls, Boeing, Axon Enterprise, Howmet Aerospace, and TransDigm. The blend of established primes and niche innovators gives the fund exposure to both the cyclical commercial-aerospace recovery and the longer-term expansion of military budgets.
Several developments could shape the fund’s path in the coming periods. The administration has proposed a $1.5 trillion defense budget for fiscal 2027, well above the prior roughly $1 trillion level. Even if Congress settles on a lower figure, the overall direction points to increased appropriations that would benefit prime contractors and suppliers. NATO’s commitment to raise defense spending toward 5% of GDP by 2035 supports a longer-term procurement cycle across Europe and allied nations. Depleted munitions stockpiles following recent conflicts also point to sustained order backlogs. A growing focus on drones, robotics, and autonomous systems could shift spending toward smaller, technology-oriented holdings within the portfolio. I reviewed some of these trends with Tickeron’s AI Daily Buy/Sell Signals for additional context on timing.
The outlook for aerospace and defense remains generally supportive, though not without challenges. Defense budgets are expanding faster than overall GDP, a structural tailwind that has historically benefited the sector during periods of geopolitical tension. At the same time, the commercial-aerospace cycle, tied to aircraft production rates and aftermarket services, provides a second, more cyclical source of demand. Interest rates and inflation remain important variables. Higher borrowing costs can pressure government budgets, while rising input costs and labor constraints affect supplier margins. Fiscal-deficit concerns and midterm-election outcomes could moderate the most optimistic spending scenarios. The equal-weighted structure means XAR’s performance is also sensitive to smaller suppliers, which can be more volatile but may respond more quickly to shifts in procurement priorities.
Over a multi-year horizon, rising global defense budgets driven by geopolitical fragmentation and allied rearmament create durable demand for platforms, munitions, and sustainment services. The integration of artificial intelligence, autonomy, and space-based capabilities is changing how militaries procure technology, potentially rewarding agile suppliers in the portfolio. Commercial space activities represent another growth area. Counterbalancing factors include higher valuation levels, potential budget caps tied to fiscal realities, and the cyclical nature of commercial aerospace. Demographic and labor trends, including skilled-workforce constraints, also influence long-term production capacity. The equal-weighted construction distributes these trends across both established primes and emerging players.
In my research on sector ETFs like this one, I often consult Tickeron’s Trend Prediction Engine to get an AI-assisted view of potential short-term trends. It provides searchable predictions and historical context that help me monitor whether conditions appear bullish, bearish, or sideways over the coming weeks or months, adding a useful data layer to the broader fundamental analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The Aroon Indicator for XAR entered a downward trend on October 23, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 122 similar instances where the Aroon Indicator formed such a pattern. In 112 of the 122 cases the stock moved lower. This puts the odds of a downward move at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XAR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 49 cases where XAR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for XAR just turned positive on October 15, 2026. Looking at past instances where XAR's MACD turned positive, the stock continued to rise in 36 of 42 cases over the following month. The odds of a continued upward trend are 86%.
Following a +0.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where XAR advanced for three days, in 291 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
XAR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category Industrials